Dataset Information


Donor-specific antibodies require preactivated immune system to harm renal transplant.

ABSTRACT: It is an unresolved issue why some kidney transplant recipients with pretransplant donor-specific HLA antibodies (DSA) show a high transplant failure rate, whereas in other patients DSA do not harm the graft. We investigated whether help from preactivated T-cells might be necessary for DSA to exert a deleterious effect.The impact of pretransplant DSA and immune activation marker soluble CD30 (sCD30) on 3-year graft survival was analyzed in 385 presensitized kidney transplant recipients.A deleterious influence of pretransplant DSA on graft survival was evident only in patients who were positive for the immune activation marker sCD30. In the absence of sCD30 positivity, 3-year graft survival was virtually identical in patients with or without DSA (83.1±3.9% and 84.3±2.8%, P=0.81). A strikingly lower 3-year graft survival rate of 62.1±6.4% was observed in patients who were both sCD30 and DSA positive (HR 2.92, P<0.001). Even in the presence of strong DSA with ?5000 MFI, the 3-year graft survival rate was high if the recipients were sCD30 negative.Pretransplant DSA have a significantly deleterious impact on graft survival only in the presence of high pretransplant levels of the activation marker sCD30.


PROVIDER: S-EPMC4972543 | BioStudies | 2016-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2018-01-01 | S-EPMC6115667 | BioStudies
2017-01-01 | S-EPMC5485490 | BioStudies
2019-01-01 | S-EPMC6625630 | BioStudies
2015-01-01 | S-EPMC4729299 | BioStudies
2019-01-01 | S-EPMC6850801 | BioStudies
2016-01-01 | S-EPMC4731103 | BioStudies
2018-01-01 | S-EPMC5791086 | BioStudies
1000-01-01 | S-EPMC4506716 | BioStudies
2013-01-01 | S-EPMC3636624 | BioStudies
2015-01-01 | S-EPMC4506275 | BioStudies